For #AlzheimersAwarenessMonth , Cumulus Neuroscience is honored to be sponsoring a webinar on Friday November 10th titled 'Leveraging Digital Biomarkers to Generate Real-World Physiological and Behavioral Data in CNS Clinical Studies'. #ENDALZ #CNS #neuroscience

Our research collaborator at the #TrinityCollegeDublin is excited to share interim data from our CNS-102 study at the Psychological Society of Ireland (PSI) Annual Meeting in Cork on Nov 8th from 2-3pm GMT Trinity College Dublin #CNS #ALS #trinitycollege #PrecisionALS #PSIConf23

Subtle changes in cognition are hard to measure in dementia clinical trials. Data presented at #CTAD2023 confirm it is feasible for #Alzheimers patients to use the Cumulus Platform to provide objective, frequent measures of cognitive function in the home.

Cumulus is proud to share that our Co-founder & CSO Brian Murphy was a featured on a panel titled “Engaging Consumers in Brain Health” moderated by Nicolas Pokorny of #Abbvie at #LausanneX on Oct 12th alongside Matt Trevithick of Blank Slate Technologies.

We are delighted to be showcased as one of the 50 companies in PwC UK's Life Sciences Future50 report, illustrating the world-class science and innovation being led by the UK. Find out more here: bit.ly/45Eo8NF
#LifeSciences #BioTech #DigitalHealth

We are delighted to be showcased as one of the 50 companies in PwC UK's Life Sciences Future50 report, illustrating the world-class science and innovation being led by the UK. Find out more: bit.ly/45Eo8NF
#LifeSciences #BioTech #DigitalHealth '

Cumulus is pleased to announce acceptance of 3 posters by the #CTAD23 Scientific Committee. Our team is excited to sharing these data with you in Boston 10/25-27. #Alzheimers #endalz #ADresearch #decentralizedclinicaltrials #clinicaltrials #digitalhealth

At #ECNP2023 in Barcelona on Oct 10th, Cumulus shared exciting new data which demonstrated that translational markers of LTP can be collected at home with minimal support using our FDA-cleared dry sensor 16-channel EEG headset. tinyurl.com/4ya99wx9

Cumulus Neuroscience is excited to announce that CSO and Co-Founder Brian Murphy, PhD is a featured panelist at the upcoming Lausanne X Workshop on October 12th. #LausanneX #Alzheimers #EndAlzheimers #CNS

tinyurl.com/mv5t9dd2

It is estimated that at least 1 in 20 children aged 18 and under worldwide are living with #ADHD . We are honored to work alongside our collaborators at Trinity College Dublin and ADMiRE, the HSE’s first specialist service for children and adolescents with ADHD.

Announcing acceptance of our poster “A low-burden visual evoked potential measurement of neuroplasticity: real-world feasibility and data quality from an at-home pilot study”. Excited to share data at #ECNP2023 Oct 10! #CNS
tinyurl.com/4ws8cve8

Cumulus Neuroscience is proud to announce that our CCO Tina Sampath will be a panelist at the upcoming HBAnet event Digital Health- Empowering the Future of Healthcare hosted by @Genentech on September 27 from 5 – 8 PM PT.

Cumulus is excited to announce we've been selected to showcase our Neuroassessment Platform at the Northern Ireland Investment Summit. On Sept 13th, join Ali Buick, Head of Global Business Development and Siggi Saevarsson, COO at the ICC, Belfast #NIIS23

September is World #Alzheimers Month. We're honored to work with INmune Bio Inc. on a Ph1 POC study of XPro1595, a protein biologic with a novel MOA targeting pathological inflammation using #digitalbiomarkers in a real-world setting, both in-clinic and at home

On Sunday our runners took part in the Hillsborough Castle Run to support JigsawYMH. Well done to all! Jigsaw focuses on supporting young people’s mental health and making mental health services more accessible.
Just Giving: tinyurl.com/5x2mj93y

BioWorld interviewed our CSO & Co-Founder Brian Murphy, PhD for an article on Fastball EEG, a new diagnostic assessment for #Alzheimers dementia being developed with collaborators at Universities of Bath and Bristol. #CNS #endalz #science #research #NIHR

Learn how the Cumulus Neuroscience platform was developed with input from the Cumulus Pharma Advisory Group (CPAG) to provide much needed objective physiological data in #CNS #clinicaltrials . #Alzheimers #endalz #digitalbiomarkers #science #research

It’s a wrap! The Cumulus Neuroscience team was honored to attend #AAIC23 where we presented our interim CNS-101 data and demoed our multimodal neuroassessment platform. #CNS #Alzheimers #endalz #digitalbiomarkers #science #research

Cumulus Neuroscience is proud to be a featured presenter at the British Association for Psychopharmacology Summer Meeting on July 26th in Manchester #BAP2023 #CNS #digitalbiomarkers #decentralizedclinicaltrials

Join Brian Murphy, PhD, CSO & Co-Founder of Cumulus Neuroscience for our #AAIC23 product theatre at 1:30 PM CEST titled, “Remote real-world assessments in CNS clinical trials using the Cumulus multimodal platform.” #Alzheimers #endalz #CNS